FOLETTA MARK G sold 7.6% of their position (4K shares) of DEXCOM INC on the open market
Open‑market sale worth $330.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/4/2026ACC: 0001093557-26-000145
-4K
Net shares
Net seller
$330.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$80.00
Trade value
$160K
% of position
3.8%
7/31/2026
52.85K→50.85K
Common Stock
Indirect
Shares
−2K
Price / share
$85.32
Trade value
$170.64K
% of position
3.9%
8/3/2026
50.85K→48.85K
Total
Net shares
−4K
Net value
-$330.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/31/2026 | S · Sale | −2K | $80.00 | $160K | 3.8% | 52.85K | 50.85K |
| Common Stock Indirect | 8/3/2026 | S · Sale | −2K | $85.32 | $170.64K | 3.9% | 50.85K | 48.85K |
| Total | −4K | -$330.64K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned6.33K
Total
6.33K direct6.33K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.33K | Direct |
| Total | 6.33K | 6.33K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported